SUV
Fluorodeoxyglucose F18
Lymphatic metastasis
Papillomavirus infections
Positron emission tomography computed tomography
Squamous cell carcinoma of head and neck
Journal
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
13
05
2021
accepted:
02
11
2021
pubmed:
16
11
2021
medline:
10
5
2022
entrez:
15
11
2021
Statut:
ppublish
Résumé
To investigate the predictive value of pretherapeutic metabolic tumor imaging using 18-fluorodeoxyglucose positron emission tomography (FDG-PET) for regional response in oropharyngeal cancer patients undergoing primary (chemo)radiation. Retrospective analysis of oropharyngeal cancer patients treated with primary (chemo)radiation at the University Hospital Zurich from 2010 to 2019 with available FDG-PET. The SUV 95 patients with a mean age of 68.5 years (SD 10.3) were included. The median pretherapeutic nodal SUV The SUV
Identifiants
pubmed: 34779928
doi: 10.1007/s00405-021-07169-7
pii: 10.1007/s00405-021-07169-7
doi:
Substances chimiques
Radiopharmaceuticals
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
3167-3177Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Dhull AK, Atri R, Dhankhar R, Chauhan AK, Kaushal V (2018) Major risk factors in head and neck Cancer: a retrospective analysis of 12-year experiences. World J Oncol 9(3):80
pubmed: 29988794
pmcid: 6031231
doi: 10.14740/wjon1104w
Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29(32):4294
pubmed: 21969503
pmcid: 3221528
doi: 10.1200/JCO.2011.36.4596
Broglie MA, Jochum W, Michel A, Waterboer T, Foerbs D, Schoenegg R et al (2017) Evaluation of type-specific antibodies to high risk-human papillomavirus (HPV) proteins in patients with oropharyngeal cancer. Oral Oncol 70:43–50
pubmed: 28622890
doi: 10.1016/j.oraloncology.2017.05.010
Goldenberg D, Begum S, Westra WH, Khan Z, Sciubba J, Pai SI et al (2008) Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck J Sci Spec Head Neck 30(7):898–903
doi: 10.1002/hed.20796
Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ et al (2019) Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet 393(10166):40–50
pubmed: 30449625
doi: 10.1016/S0140-6736(18)32779-X
Broglie MA, Stoeckli SJ, Sauter R, Pasche P, Reinhard A, de Leval L et al (2017) Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery. Head Neck 39(10):2004–2015
pubmed: 28691255
doi: 10.1002/hed.24865
Bernier J (2011) Head and neck cancer: multimodality management. Springer Science & Business Media
Grégoire V, Lefebvre J-L, Licitra L, Felip E (2010) Squamous cell carcinoma of the head and neck: EHNS–ESMO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(suppl5):184–186
doi: 10.1093/annonc/mdq185
Tupchong L, Phil D, Scott CB, Blitzer PH, Marcial VA, Lowry LD et al (1991) Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73–03. Int J Radiat Oncol Biol Phys 20(1):21–28
pubmed: 1993628
doi: 10.1016/0360-3016(91)90133-O
Rüegg P, Morand GB, Kudura K, Rupp NJ, Hüllner MW, Broglie MA (2020) Tumor cell viability in salvage neck dissections: Poor prognosis predicted by high postradiation nodal SUVmax, p16-negativity, and low nodal shrinkage. Head Neck 42(4):660–669
pubmed: 31854495
doi: 10.1002/hed.26045
Kyzas PA, Evangelou E, Denaxa-Kyza D, Ioannidis JP (2008) 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst 100(10):712–720
pubmed: 18477804
doi: 10.1093/jnci/djn125
Lim RS, Ramdave S, Beech P, Billah B, Karim MN, Smith JA et al (2016) Utility of SUV max on 18 F-FDG PET in detecting cervical nodal metastases. Cancer Imaging 16(1):39
pubmed: 27821180
pmcid: 5100181
doi: 10.1186/s40644-016-0095-z
Fleming AJ Jr, Smith SP Jr, Paul CM, Hall NC, Daly BT, Agrawal A et al (2007) Impact of [18F]-2-fluorodeoxyglucose–positron emission tomography/computed tomography on previously untreated head and neck cancer patients. Laryngoscope 117(7):1173–1179
pubmed: 17603315
doi: 10.1097/MLG.0b013e31805d017b
Cacicedo J, Navarro A, Del Hoyo O, Gomez-Iturriaga A, Alongi F, Medina JA et al (2016) Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist. Br J Radiol 89(1067):20160217
pubmed: 27416996
pmcid: 5124833
doi: 10.1259/bjr.20160217
Stalder SA, Schumann P, Lanzer M, Hüllner MW, Rupp NJ, Broglie MA et al (2020) Value of SUVmax for the prediction of bone invasion in oral squamous cell carcinoma. Biology 9(2):23
pmcid: 7167854
doi: 10.3390/biology9020023
Werner J, Hüllner MW, Rupp NJ, Huber AM, Broglie MA, Huber GF et al (2019) Predictive value of pretherapeutic maximum standardized uptake value (Suv max) in laryngeal and hypopharyngeal cancer. Sci Rep 9(1):1–10
Morand GB, Vital DG, Kudura K, Werner J, Stoeckli SJ, Huber GF et al (2018) Maximum standardized uptake value (SUV max) of primary tumor predicts occult neck metastasis in oral cancer. Sci Rep 8(1):1–7
Bredell MG, Ernst J, El-Kochairi I, Dahlem Y, Ikenberg K, Schumann DM (2016) Current relevance of hypoxia in head and neck cancer. Oncotarget 7(31):50781
pubmed: 27434126
pmcid: 5226620
doi: 10.18632/oncotarget.9549
Wilson WR, Hay MP (2011) Targeting hypoxia in cancer therapy. Nat Rev Cancer 11(6):393–410
pubmed: 21606941
doi: 10.1038/nrc3064
Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW (1997) Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 38(2):285–289
pubmed: 9226314
doi: 10.1016/S0360-3016(97)00101-6
Mehanna H, Wong W-L, McConkey CC, Rahman JK, Robinson M, Hartley AG et al (2016) PET-CT surveillance versus neck dissection in advanced head and neck cancer. N Engl J Med 374(15):1444–1454
pubmed: 27007578
doi: 10.1056/NEJMoa1514493
Schwartz DL, Rajendran J, Yueh B, Coltrera MD, LeBlanc M, Eary J et al (2004) FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg 130(12):1361–1367
pubmed: 15611393
doi: 10.1001/archotol.130.12.1361
Liao CT, Chang JTC, Wang HM, Ng SH, Hsueh C, Lee LY et al (2009) Preoperative [18F] fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys 74(4):1054–1061
pubmed: 19101096
doi: 10.1016/j.ijrobp.2008.09.045
Haerle SK, Strobel K, Ahmad N, Soltermann A, Schmid DT, Stoeckli SJ (2011) Contrast-enhanced 18F-FDG-PET/CT for the assessment of necrotic lymph node metastases. Head Neck 33(3):324–329
pubmed: 20652890
Guenzel T, Franzen A, Wiegand S, Kraetschmer S, Jahn JL, Mironczuk R et al (2013) The value of PET compared to MRI in malignant head and neck tumors. Anticancer Res 33(3):1141–1146
pubmed: 23482793
Hoang JK, Vanka J, Ludwig BJ, Glastonbury CM (2013) Evaluation of cervical lymph nodes in head and neck cancer with CT and MRI: tips, traps, and a systematic approach. Am J Roentgenol 200(1):W17–W25
doi: 10.2214/AJR.12.8960
Smeets SJ, Hesselink AT, Speel EJM, Haesevoets A, Snijders PJ, Pawlita M et al (2007) A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 121(11):2465–2472
pubmed: 17680565
doi: 10.1002/ijc.22980
Sekine T, Delso G, Zeimpekis KG, de Galiza BF, Ter Voert EE, Huellner M et al (2018) Reduction of 18F-FDG dose in clinical PET/MR imaging by using silicon photomultiplier detectors. Radiology 286(1):249–259
pubmed: 28914600
doi: 10.1148/radiol.2017162305
Sekine T, de Galiza BF, Kuhn FP, Burger IA, Stolzmann P, Huber GF et al (2017) PET+ MR versus PET/CT in the initial staging of head and neck cancer, using a trimodality PET/CT+ MR system. Clin Imaging 42:232–239
pubmed: 28129606
doi: 10.1016/j.clinimag.2017.01.003
Queiroz MA, Huellner MW (2015) PET/MR in cancers of the head and neck. Seminars in nuclear medicine. Elsevier, Amsterdam
Marcus C, Ciarallo A, Tahari AK, Mena E, Koch W, Wahl RL et al (2014) Head and neck PET/CT: therapy response interpretation criteria (Hopkins criteria)—interreader reliability, accuracy, and survival outcomes. J Nucl Med 55(9):1411–1416
pubmed: 24947059
doi: 10.2967/jnumed.113.136796
Castelli J, De Bari B, Depeursinge A, Simon A, Devillers A, Jimenez GR et al (2016) Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy. Crit Rev Oncol Hematol 108:40–51
pubmed: 27931839
doi: 10.1016/j.critrevonc.2016.10.009
Schrepfer T, Haerle SK, Strobel K, Schaefer N, Hälg RA, Huber GF (2010) The value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas. Laryngoscope 120(5):937–944
pubmed: 20422687
Kubicek GJ, Champ C, Fogh S, Wang F, Reddy E, Intenzo C et al (2010) FDG-PET staging and importance of lymph node SUV in head and neck cancer. Head Neck Oncol 2(1):19
pubmed: 20637102
pmcid: 2915991
doi: 10.1186/1758-3284-2-19
Liao CT, Chang JTC, Wang HM, Ng SH, Huang SF, Chen IH et al (2009) Preoperative [18 F]-fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes may aid in selecting patients with oral cavity squamous cell carcinoma for salvage therapy after relapse. Eur J Nucl Med Mol Imaging 36(11):1783
pubmed: 19495747
doi: 10.1007/s00259-009-1180-3
Schwartz DL, Harris J, Yao M, Rosenthal DI, Opanowski A, Levering A et al (2015) Metabolic tumor volume as a prognostic imaging-based biomarker for head-and-neck cancer: pilot results from Radiation Therapy Oncology Group protocol 0522. Int J Radiat Oncol Biol Phys 91(4):721–729
pubmed: 25752384
pmcid: 4672942
doi: 10.1016/j.ijrobp.2014.12.023
Inokuchi H, Kodaira T, Tachibana H, Nakamura T, Tomita N, Nakahara R et al (2011) Clinical usefulness of [(18) F] fluoro-2-deoxy-D-glucose uptake in 178 head-and-neck cancer patients with nodal metastasis treated with definitive chemoradiotherapy: consideration of its prognostic value and ability to provide guidance for optimal selection of patients for planned neck dissection. Int J Radiat Oncol Biol Phys 79(3):747–755
pubmed: 20434274
doi: 10.1016/j.ijrobp.2009.11.034
Shaw RJ, Lowe D, Woolgar JA, Brown JS, Vaughan ED, Evans C et al (2010) Extracapsular spread in oral squamous cell carcinoma. Head Neck J Sci Spec Head Neck 32(6):714–722
Benchetrit L, Torabi SJ, Givi B, Haughey B, Judson BL (2021) Prognostic significance of extranodal extension in HPV-mediated oropharyngeal carcinoma: a systematic review and meta-analysis. Otolaryngol Head Neck Surg 164(4):720–732
pubmed: 32838649
doi: 10.1177/0194599820951176
Mermod M, Tolstonog G, Simon C, Monnier Y (2016) Extracapsular spread in head and neck squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol 62:60–71
pubmed: 27865373
doi: 10.1016/j.oraloncology.2016.10.003
Clark J, Jeffery CC, Zhang H, Cooper T, O’Connell DA, Harris J et al (2015) Correlation of PET-CT nodal SUVmax with p16 positivity in oropharyngeal squamous cell carcinoma. J Otolaryngol Head Neck Surg 44(1):37
pubmed: 26374294
pmcid: 4570692
doi: 10.1186/s40463-015-0091-5
Yousem DM, Som PM, Hackney DB, Schwaibold F, Hendrix RA (1992) Central nodal necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT. Radiology 182(3):753–759
pubmed: 1535890
doi: 10.1148/radiology.182.3.1535890
Som PM (1987) Lymph nodes of the neck. Radiology 165(3):593–600
pubmed: 3317494
doi: 10.1148/radiology.165.3.3317494
Deron P, Vangestel C, Goethals I, De Potter A, Peeters M, Vermeersch H et al (2011) FDG uptake in primary squamous cell carcinoma of the head and neck. Nuklearmedizin 50(01):15–21
pubmed: 21052609
doi: 10.3413/nukmed-0324-10-06
Zhen W, Karnell LH, Hoffman HT, Funk GF, Buatti JM, Menck HR (2004) The National Cancer Data Base report on squamous cell carcinoma of the base of tongue. Head Neck J Sci Spec Head Neck 26(8):660–674
doi: 10.1002/hed.20064
Kamran SC, Qureshi MM, Jalisi S, Salama A, Grillone G, Truong MT (2018) Primary surgery versus primary radiation-based treatment for locally advanced oropharyngeal cancer. Laryngoscope 128(6):1353–1364
pubmed: 28988426
doi: 10.1002/lary.26903
Wuerdemann N, Wittekindt C, Sharma SJ, Prigge E-S, Reuschenbach M, Gattenlöhner S et al (2017) Risk factors for overall survival outcome in surgically treated human papillomavirus-negative and positive patients with oropharyngeal cancer. Oncol Res Treat 40(6):320–327
pubmed: 28558385
doi: 10.1159/000477097
Schache AG, Liloglou T, Risk JM, Filia A, Jones TM, Sheard J et al (2011) Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination. Clin Cancer Res 17(19):6262–6271
pubmed: 21969383
pmcid: 3188400
doi: 10.1158/1078-0432.CCR-11-0388